| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.45 | 5e-24 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-13 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.25 | 8e-12 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.25 | 7e-11 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-11 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 7e-10 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |